LZTR1 and psoriasis: Taken together, through both the short-term psoriasis model and the rechallenge model, our data identify LZTR1 as a novel driver of pro-inflammatory KC subsets that amplifies autoantigen presentation and promotes the activation of both CD8+ TRM and Tc17 cells.